Actionable genomic landscape of biliary tract cancer in the Indian population
The Oncologist · 2026
DOI: 10.1093/oncolo/oyaf430 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Sewanti Limaye und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Precision Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai 422010, India. Hauptthemen laut MEDLINE: Genomics, Biliary Tract Neoplasms, Bile Duct Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Biliary tract cancers (BTCs), including gallbladder cancer (GBC) and cholangiocarcinoma (CCA), are rare but aggressive malignancies with distinct molecular landscapes and poor prognoses. Genomic profiling has revealed significant molecular alterations, but the genomic landscape of BTC in the Indian population remains underexplored. This study aims to comprehensively characterize the mutation landscape of BTC in the Indian population.
Methods
A total of 154 BTC cases, including 69 CCA and 85 GBC, were retrospectively analyzed using data collected from various targeted sequencing panels. Somatic mutations, copy number variations (CNVs), and gene fusions in key oncogenic and tumor suppressor genes were identified from these panel reports. Downstream analyses were performed to derive key biological insights, including pathway enrichment and mutual exclusivity and co-occurrence analyses of genomic alterations.
Results
TP53 was the most frequently mutated gene (53%), followed by KRAS (18%), ARID1A (9%), IDH1 (7%), and PIK3CA (7%). Recurrent amplifications were observed in MYC (12%) and ERBB2 (9%). Pathway enrichment analysis revealed significant dysregulation in the PI3K-AKT-mTOR, Notch, and Wnt/β-catenin signaling pathways. Notably, IDH1 mutations were primarily observed in CCA, while STK11 mutations were exclusive to GBC, highlighting distinct molecular characteristics between the two subtypes. PD-L1-negative tumors exhibited distinct genomic alterations, notably SMAD4 mutations, which were associated with reduced PD-L1 expression. This loss of SMAD4, involved in TGF-β signaling, could impair immune response regulation and facilitate immune evasion.
Conclusions
This study provides a comprehensive molecular profiling of BTCs in the Indian population, revealing key genomic alterations, subtype-specific differences, and associations with immune features. The findings underscore the importance of molecular profiling in guiding personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Precision Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai 422010, India.
- Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Centre, Duarte, CA 422010, United States.
- Datar Cancer Genetics, Nashik, Maharashtra 422010, India.
- Department of Surgical Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai 51122, India.
- Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, India.
- Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka 560066, India.
ORCID-Profile: Sewanti Limaye, Damian Rieke, Milind Javle
Zitieren
APA
Limaye, S., Shreenivas, A., Patil, D., Vyas, S., George, I. A., Sambath, J., Singh, S., Madre, C., Parab, A., Kataria, P., Shah, D., Shah, N., Dawood, S., Rohatgi, N., Deshpande, R., Datta, A., Shamsi, H. A., Gaya, A., Vaid, A. K., …, & Javle, M. (2026). Actionable genomic landscape of biliary tract cancer in the Indian population. The Oncologist. https://doi.org/10.1093/oncolo/oyaf430
Vancouver
Limaye S, Shreenivas A, Patil D, Vyas S, George IA, Sambath J, et al. Actionable genomic landscape of biliary tract cancer in the Indian population. The Oncologist. 2026. doi:10.1093/oncolo/oyaf430
BibTeX
@article{Limaye2026,
author = {Limaye, Sewanti and Shreenivas, Aditya and Patil, Darshana and Vyas, Soumil and George, Irene A and Sambath, Janani and Singh, Shambhavi and Madre, Chetan and Parab, Anjali and Kataria, Pritam and Shah, Darshit and Shah, Niyati and Dawood, Shaheenah and Rohatgi, Nitesh and Deshpande, Ruturaj and Datta, Aakriti and Shamsi, Humaid Al and Gaya, Andrew and Vaid, Ashok Kumar and Kulkarni, Shriniwas and Rajappa, Senthil and Rieke, Damian and Kumar, Prashant and Datar, Rajan and Javle, Milind},
title = {Actionable genomic landscape of biliary tract cancer in the Indian population},
journal = {The Oncologist},
year = {2026},
doi = {10.1093/oncolo/oyaf430}
}
EUVIMED